AgelessRx Blog

Low Dose Naltrexone for Healthspan: What Our Real-World Study Found

Explore how Low Dose Naltrexone may target inflammaging and support healthspan, based on real-world findings from 5,500 participants. Read More
Microdosing GLP-1 for Longevity: What Our Trial Is Studying

Explore how Microdosing Semaglutide may support metabolic health, inflammation, and longevity, including what our GLP-1 trial is studying. Read More
BPC-157 as a Recovery and Repair Peptide

Explore BPC-157 as a recovery and repair peptide: how it works, reported side effects, and what the FDA’s compounding prohibition means for US access. Read More
Understanding Our SF-36 Quality of Life Study

Curious about the SF-36 quality of life study? Discover what this validated health survey measures and what our longevity research found. Read More
What The AgelessRx Rapamycin Study Revealed About Bioavailability

Fat intake, gut microbiome composition, and enzyme activity may all influence Rapamycin absorption. See what our study revealed. Read More
AgelessRx PEARL Trial: Rapamycin & LDN Bone Density Findings

Explore PEARL trial findings on Rapamycin, Low Dose Naltrexone, and bone density, including a notable case report, potential mechanisms, safety considerations, and the need for larger clinical studies. Read More
LDN and NAD+ for Long COVID Fatigue: AgelessRx Trial Findings

Low Dose Naltrexone and NAD+ were tested together for Long COVID fatigue in our trial. Learn what the results showed and why the combination worked. Read More
Acarbose Longevity Research: AgelessRx Trial Data

Our Research Team tracked Acarbose as a longevity intervention in a pilot trial. See biomarker findings, glucose data, and tolerability results. Read More
GHK-Cu: How It Works and What Research Shows

GHK-Cu is backed by decades of research. This guide covers how it works, skin and hair benefits, dosage protocols, and safe sourcing options. Read More